Company intelligence
Ambry Genetics
Finding Answers Through Quality Genetic Testing
About Ambry Genetics
Ambry Genetics, a Tempus company, translates scientific research into clinically actionable test results based upon a deep understanding of the human genome and the biology behind genetic disease. It is a leader in genetic testing that aims to improve health by understanding the relationship between genetics and disease. Its unparalleled track record of discoveries over 25 years, and growing database that continues to expand in collaboration with academic, corporate, and pharmaceutical partners, means Ambry Genetics is first to market with innovative products and comprehensive analysis that enable clinicians to confidently inform patient health decisions. Hiring Fraud Alert: Ambry has received reports of employment scams in recent months that seek financial commitments, or requests personal information from job candidates. Unsuspecting job seekers have reported receiving unsolicited contacts by phone, email or text from individual(s) posing to be or represent Ambry recruiter(s). If you’ve experienced either of these scenarios, please visit this page to learn more about hiring fraud: https://consumer.ftc.gov/articles/job-scams. Or visit https://www.ambrygen.com/company/careers/recruitment-fraud-alert to learn more about our policy on recruitment fraud. You can confirm the legitimacy of a job posting by viewing our current open roles at https://ambrygen.com/careers.
Verified activity
Signals from Ambry Genetics
5 published signals
Research & Knowledge
Ambry Genetics published a research article in the Gene Scene exploring DSC2 and its association with DSC2-related arrhythmogenic right ventricular cardiomyopathy (ARVC).
Reported by Ambry Genetics
Presence & Recognition
Ambry Genetics is attending the Rare Trials Summit in Boston next week.
Reported by Cody Buhler
Presence & Recognition
Ambry Genetics is attending the American Academy of Pediatrics Annual Meeting in San Diego from October 3-5, 2026, to discuss genetic testing and reanalysis for children with intellectual disability and global developmental delay.
Reported by Ambry Genetics
Research & Knowledge
Ambry Genetics
Reported by Ambry Genetics
Research & Knowledge
Ambry Genetics featured Frankie Fann, MS, CGC, in the GeneScene discussing NF2 and its association with NF2-related schwannomatosis.
Reported by Ambry Genetics